Article
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness.
Blood - 22 Dec 2011
Rossi Davide, Bruscaggin Alessio, Spina Valeria, Rasi Silvia, Khiabanian Hossein, Messina Monica, Fangazio Marco, Vaisitti Tiziana, Monti Sara, Chiaretti Sabina, Guarini Anna, Del Giudice Ilaria, Cerri Michaela, Cresta Stefania, Deambrogi Clara, Gargiulo Ernesto, Gattei Valter, Forconi Francesco, Bertoni Francesco, Deaglio Silvia, Rabadan Raul, Pasqualucci Laura, Foà Robin, Dalla-Favera Riccardo, Gaidano Gianluca
Abstract excerpt
The genetic lesions identified in chronic lymphocytic leukemia (CLL) do not entirely recapitulate the disease pathogenesis and the development of serious complications, such as chemorefractoriness. While investigating the coding genome of fludarabine-refractory CLL, we observed that mutations of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
